1-3 of 3
Matteo Simonelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation

Open Access
Francesca Orzan, Francesca De Bacco, Elisabetta Lazzarini, Giovanni Crisafulli, Alessandra Gasparini, Angelo Dipasquale, Ludovic Barault, Marco Macagno, Pasquale Persico, Federico Pessina, Beatrice Bono, Laura Giordano, Pietro Zeppa, Antonio Melcarne, Paola Cassoni, Diego Garbossa, Armando Santoro, Paolo M. Comoglio, Stefano Indraccolo, Matteo Simonelli, Carla Boccaccio
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (7): 1252–1266.
https://doi.org/10.1158/1078-0432.CCR-22-2903
Published: 03 April 2023
View articletitled, Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Open the PDF for Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation in another window
Includes: Supplementary data
Journal Articles

First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer

Open Access
Timothy A. Yap, Maria Vieito, Capucine Baldini, Juan Manuel Sepúlveda-Sánchez, Shunsuke Kondo, Matteo Simonelli, Rasha Cosman, Andre van der Westhuizen, Victoria Atkinson, Antoine F. Carpentier, Mario Löhr, Rebecca Redman, Warren Mason, Andres Cervantes, Emilie Le Rhun, Sebastian Ochsenreither, Louise Warren, Yumin Zhao, Sophie Callies, Shawn T. Estrem, Michael Man, Leena Gandhi, Emin Avsar, Davide Melisi
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (24): 6666–6676.
https://doi.org/10.1158/1078-0432.CCR-21-1504
Published: 15 December 2021
View articletitled, First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer
Open the PDF for First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer in another window
Includes: Supplementary data
Journal Articles

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Free
Paolo Andrea Zucali, Elisa Giovannetti, Annarita Destro, Manlio Mencoboni, Giovanni Luca Ceresoli, Letizia Gianoncelli, Elena Lorenzi, Fabio De Vincenzo, Matteo Simonelli, Matteo Perrino, Andrea Bruzzone, Erik Thunnissen, Gianni Tunesi, Laura Giordano, Massimo Roncalli, Godefridus J. Peters, Armando Santoro
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2581–2590.
https://doi.org/10.1158/1078-0432.CCR-10-2873
Published: 14 April 2011
View articletitled, Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin
Open the PDF for Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin in another window